|
1A5H
CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE
Deposited 1998-02-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
311–562(252 aa)
Fragment:LIGHT CHAIN, CATALYTIC DOMAIN
Chain C
298–304(7 aa)
Fragment:HEAVY CHAIN FRAGMENT, CATALYTIC DOMAIN
|
Not recorded
|
BBA 2,7-BIS-(4-AMIDINOBENZYLIDENE)-CYCLOHEPTAN-1-ONE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.5;pH 4.5
|
Resolution 2.90 Å
|
|
1A5H
CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE
Deposited 1998-02-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
311–562(252 aa)
Fragment:LIGHT CHAIN, CATALYTIC DOMAIN
Chain D
298–304(7 aa)
Fragment:HEAVY CHAIN FRAGMENT, CATALYTIC DOMAIN
|
Not recorded
|
BBA 2,7-BIS-(4-AMIDINOBENZYLIDENE)-CYCLOHEPTAN-1-ONE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.5;pH 4.5
|
Resolution 2.90 Å
|
|
1BDA
CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE)
Deposited 1998-05-07
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
298–562(265 aa)
Fragment:UNP residues 298-562
|
Mutation:DELETION MUTANT
|
2Z0 N-{[5-(dimethylamino)naphthalen-2-yl]sulfonyl}-L-alpha-glutamyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl) butyl]glycinamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.2;pH 8.2
|
Resolution 3.35 Å
|
|
1BDA
CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE)
Deposited 1998-05-07
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
298–562(265 aa)
Fragment:UNP residues 298-562
|
Mutation:DELETION MUTANT
|
2Z0 N-{[5-(dimethylamino)naphthalen-2-yl]sulfonyl}-L-alpha-glutamyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl) butyl]glycinamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.2;pH 8.2
|
Resolution 3.35 Å
|
|
1PK2
SOLUTION STRUCTURE OF THE TISSUE-TYPE PLASMINOGEN ACTIVATOR KRINGLE 2 DOMAIN COMPLEXED TO 6-AMINOHEXANOIC ACID AN ANTIFIBRINOLYTIC DRUG
Deposited 1991-09-16
|
Different construct
Different ligand/ion
Different experimental method
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
209–298(90 aa)
|
Not recorded
|
ACA 6-AMINOHEXANOIC ACID × 1
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
1PML
KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURES
Deposited 1994-04-25
|
Different construct
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
213–298(86 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.38 Å
|
|
1PML
KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURES
Deposited 1994-04-25
|
Different construct
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
213–298(86 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.38 Å
|
|
1PML
KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURES
Deposited 1994-04-25
|
Different construct
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
213–298(86 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.38 Å
|
|
1RTF
COMPLEX OF BENZAMIDINE WITH THE CATALYTIC DOMAIN OF HUMAN TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR [(TC)-T-PA]
Deposited 1995-11-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
311–562(252 aa)
Fragment:CATALYTIC DOMAIN
|
Not recorded
|
PO4 PHOSPHATE ION × 1
BEN BENZAMIDINE × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.30 Å
R-free 0.265
|
|
1TPG
F1-G MODULE PAIR RESIDUES 1-91 (C83S) OF TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) (NMR, 298K, PH2.95, REPRESENTATIVE STRUCTURE)
Deposited 1995-06-14
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–126(91 aa)
|
Mutation:C83S
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
1TPM
SOLUTION STRUCTURE OF THE FIBRIN BINDING FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE
Deposited 1993-05-26
|
Different construct
Different ligand/ion
Different experimental method
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–85(50 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
1TPN
SOLUTION STRUCTURE OF THE FIBRIN BINDING FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE
Deposited 1993-05-26
|
Different construct
Different ligand/ion
Different experimental method
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
36–85(50 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
5BRR
Michaelis complex of tPA-S195A:PAI-1
Deposited 2015-06-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
311–562(252 aa)
Fragment:UNP residues 311-562
|
Mutation:C120A, N173Q, S203A
|
GOL GLYCEROL × 4
PGE TRIETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;298.15 K;8% PEG 6000, 0.1 M Tris-HCl
|
Resolution 3.16 Å
R-free 0.276
|
|
5ZLZ
Structure of tPA and PAI-1
Deposited 2018-03-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
311–561(251 aa)
|
Mutation:C430A, F458E, N483Q, S513A
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;4-8% PEG 3350, 20 mM bis-Tris-HCl pH 7.0
|
Resolution 3.58 Å
R-free 0.312
|